Carregant...

2-Oxoamide inhibitors of cytosolic group IVA phospholipase A(2) with reduced lipophilicity

Cytosolic GIVA phospholipase A(2) (GIVA cPLA(2)) initiates the eicosanoid pathway of inflammation and thus inhibitors of this enzyme constitute novel potential agents for the treatment of inflammatory diseases. Traditionally, GIVA cPLA(2) inhibitors have suffered systemically from high lipophilicity...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bioorg Med Chem
Autors principals: Antonopoulou, Georgia, Magrioti, Victoria, Kokotou, Maroula G., Nikolaou, Aikaterini, Barbayianni, Efrosini, Mouchlis, Varnavas D., Dennis, Edward A., Kokotos, George
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014611/
https://ncbi.nlm.nih.gov/pubmed/27522578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2016.07.057
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!